Cellectar Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cellectar Biosciences, Inc. on September 29, 2017. The report discloses a Regulation FD event regarding an upcoming investor presentation.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a specific event and does not contain financial statements.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing.
Guidance, Outlook, and Management Commentary
On September 29, 2017, the company announced that President and Chief Executive Officer Jim Caruso will present and meet with investors at the MicroCap Conference. The event is scheduled for Thursday, October 5, 2017, at 12:30 PM ET at the Essex House in New York City. A press release detailing this event is included as Exhibit 99.1.
Key Facts for Investor Verification
- CEO Jim Caruso is scheduled to present at the MicroCap Conference on October 5, 2017.
- The presentation will occur at the Essex House in New York City at 12:30 PM ET.
- The report was signed by John P. Hamill, Interim Chief Financial Officer.
- No financial data or operational results are included in this specific filing.